Antibiotics Use for Respiratory Diseases
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antibiotics Use and Antimicrobial Stewardship".
Deadline for manuscript submissions: 10 October 2024 | Viewed by 124
Special Issue Editors
Interests: COVID-19; clinical
Special Issues, Collections and Topics in MDPI journals
Interests: respiratory system; cognition; cardiovascular health
Special Issues, Collections and Topics in MDPI journals
Interests: obstetrics; maternal–fetal medicine; infectious disease; prediction
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The intersection of the use of antibiotics and respiratory diseases is a critical and complex aspect of modern healthcare. Respiratory diseases encompass a broad spectrum of illnesses, ranging from the common cold and flu to more severe conditions like pneumonia and bronchitis. While these ailments can be caused by various pathogens, including bacteria and viruses, the role of antibiotics in their treatment is a subject of careful consideration and ongoing research.
Antibiotics, powerful medications designed to combat bacterial infections, have revolutionized medical treatment and saved countless lives since their discovery; however, their effectiveness is limited to bacterial infections, and they are not effective against viruses, which are responsible for the majority of respiratory illnesses. These crucial challenges underscore the importance of accurate diagnosis and appropriate prescribing practices to ensure optimal patient outcomes while combating the growing threat of antibiotic resistance.
In this Special Issue, we will explore the relationship between antibiotics and respiratory diseases, examining the role of antibiotics in treating bacterial respiratory infections, the challenges of distinguishing between bacterial and viral illnesses, and the implications of antibiotic resistance for public health. By gaining a deeper understanding of these issues, we can better navigate the complexities of respiratory disease management and promote judicious antibiotic use to preserve their efficacy for future generations.
Dr. Mirela Loredana Grigoraş
Prof. Dr. Cristian Oancea
Dr. Cosmin Citu
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antimicrobial resistance
- respiratory diseases
- diagnostics
- co-infection
- healthcare-associated infection
